1 | Abatacept, rituximab or tocilizumab | 3件: Abatacept Abatacept, Rituximab, Tocilizumab | 3件: D02596
D02596
,
D02994
(Name: Rituximab),
D03203
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 |
2 | ABP 798 - Biosimilar to rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
3 | ABP 798 Biosimilar to Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
4 | Administration of rituximab and methylprednisolone | 2件: Methylprednisolone Methylprednisolone, Rituximab | 2件: D00407
D00407
,
D02994
(Name: Rituximab) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
5 | Alemtuzumab and Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: D02802
D02802
,
D02994
(Name: Rituximab) | 2件: CD52 CD52, MS4A1 💬 | 2件: , Hematopoietic cell lineage 💬 | 1件: 60 60 |
6 | Alemtuzumab, Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: D02802
D02802
,
D02994
(Name: Rituximab) | 2件: CD52 CD52, MS4A1 💬 | 2件: , Hematopoietic cell lineage 💬 | 1件: 63 63 |
7 | Belimumab in SLE patients / Rituximab in RA patients | 2件: Belimumab Belimumab, Rituximab | 2件: D02994
D02994
(Name: Rituximab),
D03068
| 2件: MS4A1 MS4A1, TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 |
8 | Bendamustine, Rituximab | 2件: Bendamustine Bendamustine, Rituximab | 2件: D02994
D02994
(Name: Rituximab),
D07501
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
9 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | 3件: Azathioprine Azathioprine, Dexamethasone, Rituximab | 3件: D00238
D00238
,
D00292
,
D02994
(Name: Rituximab) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
10 | Combination of Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
11 | Combination of Rituximab with subcutaneous belimumab | 2件: Belimumab Belimumab, Rituximab | 2件: D02994
D02994
(Name: Rituximab),
D03068
| 2件: MS4A1 MS4A1, TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 63 63 |
12 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |
13 | Cyclophosphamide/Rituximab | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
,
D02994
(Name: Rituximab),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
14 | Dexamethasone and Rituximab | 2件: Dexamethasone Dexamethasone, Rituximab | 2件: D00292
D00292
,
D02994
(Name: Rituximab) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
15 | Double-Blind Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 51 51 |
16 | Dr. Reddy’s Rituximab (DRL_RI) 100mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
17 | Dr. Reddy’s Rituximab (DRL_RI) 500mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
18 | Eltrombopag combining rituximab | 2件: Eltrombopag Eltrombopag, Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
19 | Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab | 4件: Abatacept Abatacept, Rituximab, Sarilumab, Tocilizumab | 4件: D02596
D02596
,
D02994
(Name: Rituximab),
D03203
,
D10161
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 |
20 | Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
21 | GP2013 - A Proposed biosimilar rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
22 | IDEC-C2B8 (rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
23 | Immunosuppressive treatment (eg, rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 64 64 |
24 | Individualized dose of rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
25 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | 12件: Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | 10件: D01370
D01370
,
D02802
,
D02994
(Name: Rituximab),
D03846
,
D05218
,
D06886
,
D09314
,
D10001
,
D10172
,
D11215
| 7件: CD52 CD52, DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 | 31件: , Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 | 1件: 13 13 |
26 | Intravenous Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 66 66 |
27 | MabionCD20 (candidate biosimilar to rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
28 | MabThera (Rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 13 13, 46, 49, 53 |
29 | Mabthera or biosimilar Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
30 | Mabthera or biosimilar rituximab product | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
31 | MabThera® (rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
32 | Originator rituximab - Rituxan ® or MabThera ® | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
33 | Perfusion of treatment Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
34 | Prednisone, low dose rituximab | 2件: Prednisone Prednisone, Rituximab | 2件: D00473
D00473
,
D02994
(Name: Rituximab) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
35 | RhTPO in combination with Rituximab | 2件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
36 | Rituxan (INN: Rituximab), brand name in the United States | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
37 | Rituxan (INN: Rituximab), brand name in the US | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
38 | Rituxan (rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
39 | Rituxan® (rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
40 | RITUXIMAB | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
41 | Rituximab (anti-CD20) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 |
42 | Rituximab (Arm A) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 |
43 | Rituximab (Arm B) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 |
44 | Rituximab (EU) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
45 | Rituximab (genetical recombination) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 14 14 |
46 | Rituximab (MABTHERA® or RITUXAN®). | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 35 35, 61 |
47 | Rituximab (Mabthera®) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
48 | Rituximab (Rituxan) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 11 11 |
49 | Rituximab (RTX) and Azathioprine (AZA) | 2件: Azathioprine Azathioprine, Rituximab | 2件: D00238
D00238
,
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 65 65 |
50 | Rituximab (US) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
51 | Rituximab - MabThera | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
52 | Rituximab 1g IV | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 162 162 |
53 | Rituximab [MabThera/Rituxan] | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 63 |
54 | Rituximab [MabThera] | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
55 | Rituximab and Cyclophosphamide IV | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
,
D02994
(Name: Rituximab),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 35 35 |
56 | Rituximab and Hyaluronidase Human | 2件: Hyaluronidase Hyaluronidase, Rituximab | 4件: D02994
D02994
(Name: Rituximab),
D04455
,
D04456
,
D06604
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 331 331 |
57 | Rituximab combined with Omalizumab | 2件: Omalizumab Omalizumab, Rituximab | 2件: D02994
D02994
(Name: Rituximab),
D05251
| 2件: FCER1A FCER1A, MS4A1 💬 | 5件: Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 162 162 |
58 | Rituximab combined with tacrolimus induction + rituximab maintenance | 2件: Rituximab Rituximab, Tacrolimus | 3件: D00107
D00107
,
D02994
(Name: Rituximab),
D08556
| 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
59 | Rituximab combined with tacrolimus induction + tacrolimus maintenance | 2件: Rituximab Rituximab, Tacrolimus | 3件: D00107
D00107
,
D02994
(Name: Rituximab),
D08556
| 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
60 | Rituximab Infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 222 |
61 | Rituximab IT | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
62 | Rituximab IV | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
63 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
64 | Rituximab MabThera | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
65 | Rituximab, Cyclophosphamide, and Corticosteroids | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
,
D02994
(Name: Rituximab),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
66 | Rituximab, Mabthera | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 |
67 | Rituximab, MTX, folic acid | 2件: Folic acid Folic acid, Rituximab | 2件: D00070
D00070
,
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
68 | Rituximab, observational study amon patients with active RA | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
69 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
70 | Rituximab-Pfizer | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
71 | Rituximab-Pfizer (PF-05280586) x 3 courses | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
72 | Rituximab-US + Rituximab-Pfizer x 2 Courses | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
73 | Rituximab/ Mabthera | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 271 271 |
74 | SAIT101 (proposed rituximab biosimilar) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
75 | SAIT101 (rituximab biosimilar) | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
76 | Standard dose of rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
77 | The Standard Steroid Treatment, Plasma Exchange and rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
(Name: Rituximab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |